Tat PTD-Endostatin-RGD recombinant protein and preparation method and application thereof
A recombinant protein and transduction protein technology, applied in the fields of peptide/protein components, chemical instruments and methods, recombinant DNA technology, etc., can solve the problem of no fusion expression, improve targeting and residence time, and eliminate the need for enzyme digestion The effect of recovery, rapid DNA ligation reaction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] Embodiment 1: Preparation of TatPTD-Endostatin-RGD fusion protein
[0053] 1. The construction of fusion gene: adopt the method for PCR to obtain fusion gene with TatPTD-Es as template (results see Figure 1a-Figure 1b ), and recycle.
[0054] 2. Double digestion of the empty plasmid pET28a: the E. coli expression plasmid pET28a was double digested with BamHI and XhoI, and the fragments were recovered.
[0055] 3. Ligation of the fusion gene and the plasmid: Add 100 ng of the recovered product from PCR and 100 ng of the product recovered from the digestion of the empty plasmid into the Gibson polymerization ligation reaction system, react at 50°C for 1 h, and the ligated product is used for the next transformation.
[0056] 4. Transformation of recombinant plasmids: quickly add 6 μl of the above ligation solution to 100 μl of pre-cooled competent cells E.coliDH5α and mix well, ice-bath for 30 minutes, heat shock at 42°C for 90 seconds, ice-bath for 2-3 minutes, add 900...
Embodiment 2
[0065] Example 2: Research on the biological activity of TatPTD-Endostatin-RGD fusion protein
[0066] Investigate the activity of TatPTD-Es-RGD in inhibiting the proliferation of endothelial cells: with Es, TatPTD-Es, Es-RGD as the control (the other three proteins used as the control here are prepared in the same way as TatPTD-Es-RGD), using CCK- 8 method to investigate the activity of purified TatPTD-Es-RGD in inhibiting the proliferation of vascular endothelial cells, the specific implementation steps are as follows:
[0067] The cryopreserved solution of human umbilical vein endothelial cells (EAHY926) was quickly thawed in a 37°C water bath, centrifuged at 800r / min for 3min, and the supernatant was discarded. Resuspend the cell pellet with sterile PBS, centrifuge at 800r / min for 3min, and discard the supernatant. The cell pellet was resuspended with DMEM medium (containing 10% FBS) and blown evenly to form a cell suspension, and the cell count was performed on a cell co...
Embodiment 3
[0070] Example 3: Inhibition of TatPTD-Es-RGD on Chick Embryo Chorioallantoic Membrane Angiogenesis (CAM) Generation
[0071] 1. Test method:
[0072] 1.1 The method of incubating CAM: the method is as follows: select well-growth white preserved eggs from breeder farms with a fertilization rate greater than 90% (clean and smooth surface, uniform size, standard egg shape, uniform stomata and air cells), and use them after cleaning. 1‰ benzalkonol was used to wipe and disinfect the shell of the eggs, and the eggs were cultured in an insulated electric heating constant temperature incubator at a temperature of (38±1)°C and a humidity of 60-80%, with certain ventilation condition. The air cell of the egg is upward, and the long axis is at an angle of about 70°-80° to the egg tray. Turn the egg 3 times a day, and the angle of the egg turning should be 45° in the horizontal position. After the eggs were incubated for 5 days, the eggs were illuminated with an egg lamp, and well-de...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com